Does Salicornia europaea improve memory or brain function?

One 12-week RCT with 63 participants found Salicornia europaea supplementation improved frontal executive function scores compared to placebo, suggesting modest cognitive benefits. Preclinical studies in microglial cells also show it suppresses neuroinflammatory NF-κB signaling, which may support brain health indirectly. However, only one human trial exists, so conclusions about memory or broader cognitive enhancement remain premature.

Can Salicornia europaea help lower blood sugar?

In vitro studies demonstrate that Salicornia europaea extracts inhibit α-amylase activity and block SGLT1-mediated glucose uptake in intestinal cells, two mechanisms that could reduce postprandial blood glucose. No human clinical trials have yet tested its effects on blood sugar, HbA1c, or insulin sensitivity in diabetic patients. These findings are promising but cannot be translated into clinical recommendations without human trial data.

What are the active compounds in Salicornia europaea?

Salicornia europaea contains isorhamnetin, quercetin glycosides, kaempferol derivatives, and various polyphenolic antioxidants as its primary bioactive constituents. It also provides minerals including calcium, magnesium, and notably high sodium due to its halophytic growing environment. These polyphenols are believed responsible for its observed α-amylase inhibitory, antioxidant, and anti-neuroinflammatory activities.

Is Salicornia europaea the same as glasswort or sea asparagus?

Yes, Salicornia europaea is commonly called glasswort, marsh samphire, or sea asparagus, and belongs to the Amaranthaceae family. It is a salt-tolerant succulent that grows in coastal marshes and has been consumed as a food vegetable across Europe and Asia for centuries. Supplement research uses standardized extracts of this plant rather than the raw vegetable form.

What is the studied dosage of Salicornia europaea supplement?

The single published human RCT that found cognitive benefits used a Salicornia europaea extract over a 12-week supplementation period, though the exact milligram dosage was not publicly specified in available summaries. No consensus dosing range has been established due to the very limited human trial data available. Until more trials define an effective and safe dose, standardized supplemental dosing recommendations cannot be reliably made.

What foods contain Salicornia europaea naturally, and can I get sufficient amounts from diet alone?

Salicornia europaea, commonly known as sea asparagus or glasswort, grows in coastal salt marshes and is primarily available as a fresh or pickled vegetable in specialty markets and cuisines bordering salt water regions. While it can be incorporated into salads and cooked dishes, the concentrated bioactive compounds studied in clinical trials are difficult to obtain from whole food consumption alone, making supplementation the more practical option for therapeutic doses. A single serving of fresh sea asparagus provides general micronutrients but not the standardized extract doses used in the human RCT (n=63) demonstrating frontal executive function improvements.

Is Salicornia europaea safe to take with diabetes medications or blood pressure drugs?

While in vitro studies suggest Salicornia may inhibit α-amylase and SGLT1-mediated glucose uptake, no human clinical trials have evaluated potential interactions with antidiabetic or antihypertensive medications. Individuals taking diabetes medications or blood pressure drugs should consult a healthcare provider before adding Salicornia supplements, as additive effects could theoretically lower blood glucose or blood pressure beyond therapeutic intent. The current evidence base is insufficient to establish safety or interaction profiles in medicated populations.

How strong is the clinical evidence for Salicornia europaea compared to other neuroprotective supplements?

Salicornia europaea has one human RCT (n=63, 12 weeks) showing modest improvements in frontal executive function, supported by preclinical anti-neuroinflammatory effects in microglial cell models. This evidence level is limited compared to more extensively studied neuroprotective agents like curcumin or ginkgo biloba, which have multiple human trials; however, the mechanistic anti-neuroinflammatory data is promising for future research. Most purported benefits regarding blood sugar and atherosclerosis remain preclinical (in vitro/animal studies) and lack human validation.

Salsola (Salicornia europaea)

Salicornia europaea (glasswort) is a halophytic sea vegetable containing bioactive flavonoids, isorhamnetin, and polyphenols that modulate glucose metabolism and neuroinflammatory pathways. Its primary studied mechanisms include inhibition of the carbohydrate-digesting enzyme α-amylase and suppression of microglial NF-κB signaling.

Category: Marine-Derived Evidence: 2/10 Tier: Emerging

Salsola (Salicornia europaea) — Hermetica Encyclopedia

Origin & History

Salicornia europaea (also known as glasswort) is a succulent halophyte plant native to coastal salt marshes across Europe, Asia, and North America, thriving in high-salinity environments. Extracts are typically prepared by desalting the plant material followed by ethanol or hot water extraction to concentrate bioactive compounds including polyphenols, flavonoids, saponins, and fatty acids.

Historical & Cultural Context

Salicornia europaea has been used in folk medicine for obesity, diabetes, and cancer, though specific traditional medicine systems or historical contexts are not well-documented. It is recognized as an emerging nutrient-dense halophyte with nutraceutical potential but lacks deep traditional medicine lineage.

Health Benefits

• Modest improvement in frontal executive function based on one human RCT (n=63, 12 weeks)
• Anti-neuroinflammatory effects demonstrated in preclinical microglial cell studies
• Potential anti-diabetic properties through α-amylase and SGLT1-mediated glucose uptake inhibition (in vitro evidence only)
• Anti-atherosclerotic effects via suppression of vascular smooth muscle cell proliferation (animal studies)
• General antioxidant activity attributed to polyphenol and flavonoid content (preliminary evidence)

How It Works

Salicornia europaea extracts inhibit α-amylase and sodium-glucose cotransporter 1 (SGLT1), reducing intestinal glucose absorption and postprandial blood sugar spikes in vitro. Its polyphenolic constituents, including isorhamnetin and quercetin derivatives, suppress lipopolysaccharide-induced NF-κB and MAPK signaling cascades in BV2 microglial cells, reducing pro-inflammatory cytokines such as TNF-α and IL-6. These combined mechanisms suggest potential relevance for metabolic and neuroinflammatory conditions, though in vivo confirmation beyond one human trial remains limited.

Scientific Research

Evidence is limited to one 12-week randomized, double-blind, placebo-controlled trial (n=63) testing 470 mg/day desalted extract in mild cognitive impairment patients, showing no significant primary cognitive outcomes but modest frontal executive function improvement (PMIDs: 33199752, 29740000, PMC7670404). No other human RCTs or meta-analyses exist; remaining evidence comes from preclinical cell and animal studies.

Clinical Summary

A single randomized controlled trial (n=63, 12 weeks) found that Salicornia europaea supplementation produced modest but statistically significant improvements in frontal executive function compared to placebo in adults. Preclinical data from microglial cell line studies support anti-neuroinflammatory properties, but no human trials have directly validated these neuroinflammatory outcomes. Anti-diabetic effects, including SGLT1 inhibition and α-amylase suppression, are supported only by in vitro evidence and have not been confirmed in human metabolic trials. Overall, the evidence base is preliminary and insufficient to establish definitive clinical recommendations.

Nutritional Profile

Salicornia europaea (glasswort/sea asparagus) is a halophyte with a distinctive nutritional profile shaped by its saline habitat. Macronutrients (dry weight basis): protein 8–15% (containing essential amino acids including glutamic acid, alanine, and glycine as dominant fractions); dietary fiber 20–30% (including pectin and hemicellulose fractions); lipids 2–5% with favorable unsaturated fatty acid profile (linoleic acid C18:2 and oleic acid C18:1 predominant); carbohydrates 35–50%. Minerals (notably high due to halophytic salt accumulation): sodium 3,000–8,000 mg/100g dry weight (primary concern for high-sodium content limiting unrestricted consumption); potassium 1,200–2,500 mg/100g DW; magnesium 400–800 mg/100g DW; calcium 600–1,200 mg/100g DW; iron 15–40 mg/100g DW; zinc 2–6 mg/100g DW; iodine present in moderate trace amounts reflecting marine environment. Vitamins: vitamin C (ascorbic acid) approximately 20–40 mg/100g fresh weight; vitamin A precursors (beta-carotene) detected; B-vitamins present at modest levels including B1, B2, and niacin. Key bioactive compounds: schaftoside and isoschaftoside (C-glycosyl flavones, primary polyphenols linked to SGLT1 inhibition and α-amylase inhibition activity); isoquercitrin and quercetin glycosides; betacyanins and betaxanthins (betalain pigments contributing antioxidant capacity); saponins; chlorogenic acid derivatives; ursolic and oleanolic acid triterpenes. Total polyphenol content reported at 15–45 mg GAE/g dry extract depending on harvest season and extraction method. Bioavailability notes: high sodium content may limit daily intake volumes in clinical settings; polyphenol bioavailability is moderately constrained by fiber matrix binding and glycosylation; mineral bioavailability may be reduced by co-occurring oxalates and phytates; lipid-soluble compounds benefit from co-consumption with dietary fat.

Preparation & Dosage

The only clinically studied dosage is 470 mg/day of desalted ethanol extract (PM-EE) in divided doses, tested for 12 weeks in tablet form. No standardization details or dosages for powder or other forms have been clinically validated. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginkgo biloba, Lion's Mane, Omega-3 fatty acids, Curcumin, Green tea extract

Safety & Interactions

Salicornia europaea has a long history of use as an edible sea vegetable and is generally considered food-safe, but formal toxicological profiling of concentrated extracts is lacking. Due to its SGLT1-inhibiting activity, caution is warranted in individuals taking antidiabetic medications such as SGLT2 inhibitors or insulin, as additive hypoglycemic effects are theoretically possible. Its high natural sodium content may be relevant for individuals managing hypertension or on sodium-restricted diets. Safety data in pregnant or breastfeeding individuals is absent, and supplemental use should be avoided in these populations until further research is available.